ASG. Aurora Spine Corp

Aurora Spine’s Patent Related to DEXA Technology™ Patient-Matched Implant Technology Issued by the United States Patent Office

Aurora Spine’s Patent Related to DEXA Technology™ Patient-Matched Implant Technology Issued by the United States Patent Office
EN
05/10/2020

Underlying

ASG.Aurora Spine Corp

To request access to management, click here to engage with our
partner Phoenix-IR's CorporateAccessNetwork.com

Reports on Aurora Spine Corp

 PRESS RELEASE
Free
ASG. Aurora Spine Co...

Aurora Spine Announces Issuance of Two U.S. Patents

Aurora Spine Announces Issuance of Two U.S. Patents Tenth Issued Patent for the ZIP™ Implant Family CARLSBAD, CA, Jan. 08, 2026 (GLOBE NEWSWIRE) -- Aurora Spine Corporation (“Aurora Spine” or the “Company”) (TSXV: ASG) (OTCQB: ASAPF), a leader in minimally invasive spine and interventional pain solutions, today announced the issuance of two independent U.S. patents by the US Patent and Trademark Office.  The issuance of these patents strengthens the company’s intellectual property portfolio and reinforces its long-term innovation strategy across multiple spinal implant platforms. New...

January 8, 2026 1 EN
 PRESS RELEASE
Free
ASG. Aurora Spine Co...

Aurora Spine Corporation Announces Record Third Quarter Financial Resu...

Aurora Spine Corporation Announces Record Third Quarter Financial Results - Company to host conference call Today, November 18th at 11am ET/8am PT – NOT FOR DISTRIBUTION IN THE UNITED STATES OR OVER UNITED STATES WIRE SERVICES CARLSBAD, Calif., Nov. 18, 2025 (GLOBE NEWSWIRE) -- Aurora Spine Corporation (“Aurora Spine” or the “Company”) (TSXV: ASG) (OTCQB: ASAPF), a leader in minimally invasive spine and interventional pain solutions, today announced its financial results for third quarter ended September 30, 2025. All figures are in U.S. dollars. Financial and Business Highlights ...

November 18, 2025 1 EN
 PRESS RELEASE
Free
ASG. Aurora Spine Co...

Aurora Spine Corporation Announces Participation at the North American...

Aurora Spine Corporation Announces Participation at the North American Spine Society Annual Meeting Company to Showcase Cutting-Edge Innovations at Booth #1622  CARLSBAD, Calif., Nov. 12, 2025 (GLOBE NEWSWIRE) -- Aurora Spine Corporation ("Aurora Spine" or the "Company") (TSXV: ASG) (OTCQB: ASAPF), a leader in the development of groundbreaking medical devices for spinal surgery, today announced its participation at the 2025 North American Spine Society ("NASS") Annual Meeting. The event will take place from November 14-16, 2025, at the Colorado Convention Center, in Denver, Colorado. A...

November 12, 2025 1 EN
 PRESS RELEASE
Free
ASG. Aurora Spine Co...

Aurora Spine Launches New Biologics Portfolio

Aurora Spine Launches New Biologics Portfolio New Aurora Biologics Division Establishes Aurora Spine as a Vertically Integrated Source for Spinal Implants and Biologics CARLSBAD, CA, Oct. 27, 2025 (GLOBE NEWSWIRE) -- Aurora Spine Corporation (“Aurora Spine”) (TSXV: ASG) (OTCQB: ASAPF), a leader in minimally invasive spine and interventional pain solutions, today announced the launch of Aurora Biologics, a new division dedicated to advancing spinal fusion success through best-in-class biologic innovation. The establishment of Aurora Biologics creates seamless synergy across Aurora’s gr...

October 27, 2025 1 EN
 PRESS RELEASE
Free
ASG. Aurora Spine Co...

Aurora Spine Announces Proposed Warrant Extension

Aurora Spine Announces Proposed Warrant Extension CARLSBAD, Calif., Oct. 20, 2025 (GLOBE NEWSWIRE) -- Aurora Spine Corporation (“Aurora Spine” or the “Company”) (TSXV: ASG) (OTCQB: ASAPF), a leader in innovative spine and interventional pain management solutions, today announces that, subject to the approval of the TSX Venture Exchange,  it is proposing to amend the terms of an aggregate of 6,445,939 common share purchase warrants (the “Warrants”) by extending the expiry date of the Warrants until October 15, 2026. The Warrants, with an exercise price of CDN$0.50 and an original expiry...

October 20, 2025 1 EN

ResearchPool Subscriptions

Get the most out of your insights

Get in touch